I am a social/behavioral scientist interested in the development of evidence-based behavioral interventions to facilitate patient engagement and activation. In addition, I am exploring how medical evidence (risk, benefit, and health outcomes) is constructed and communicated within a patient-HCP clinical encounter to promote shared-treatment decision making and behavior change. Finally, I am interested in bringing a more patient-centered approach to drug development through patient reported and defined outcomes and patient focused benefit-risk assessments.
In my previous roles at Bristol-Myers Squibb, Pfizer, and AstraZeneca I conducted research to assess the effectiveness of the FDA mand...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
